VYNE Therapeutics Inc. (VYNE)
1.69
-0.09 (-5.06%)
At close: Mar 28, 2025, 3:59 PM
1.69
0.00%
After-hours: Mar 28, 2025, 04:37 PM EDT
VYNE Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Net Income | -39.83M | -28.45M | -23.21M | -73.33M | -255.57M | -73.7M | -51.45M | -29.08M | -14.07M | -4.61M |
| Depreciation & Amortization | 4K | n/a | 72K | 109K | 341K | 700K | 22K | 8K | 4K | n/a |
| Stock-Based Compensation | 3.3M | 3.31M | 4.3M | 8.08M | 18.1M | 6.7M | 3.64M | 1.45M | 573K | 65K |
| Other Working Capital | -1.01M | 214K | -349K | -371K | -4.17M | 1.41M | -8.55M | -1.74M | 10.18M | 360K |
| Other Non-Cash Items | -2.44M | -254K | -12.64M | 2.47M | 84.07M | -691K | -774K | 31K | 705K | 65K |
| Deferred Income Tax | n/a | n/a | n/a | 1.52M | 56.3M | n/a | n/a | 60K | -573K | n/a |
| Change in Working Capital | 5M | 60K | 2.28M | 4.78M | -40.33M | 1.89M | -4.17M | -722K | 11.07M | 360K |
| Operating Cash Flow | -33.97M | -25.34M | -29.2M | -56.37M | -137.08M | -65.1M | -52.73M | -28.25M | -2.29M | -4.18M |
| Capital Expenditures | -117K | n/a | n/a | n/a | -113K | -11K | -140K | -27K | -31K | n/a |
| Acquisitions | n/a | 5M | 15.67M | n/a | 38.64M | 40K | n/a | -25K | n/a | n/a |
| Purchase of Investments | -60.52M | -62.35M | n/a | n/a | -38.64M | -83.4M | -126.7M | -64.15M | -55.31M | n/a |
| Sales Maturities Of Investments | 84M | n/a | n/a | 1.03M | 50.58M | 124.78M | 92.96M | 49.11M | 17.85M | n/a |
| Other Investing Acitivies | n/a | n/a | 15.67M | n/a | 38.64M | -40K | n/a | 25K | n/a | n/a |
| Investing Cash Flow | 23.36M | -57.35M | 15.67M | 1.03M | 89.11M | 41.37M | -33.88M | -15.06M | -37.49M | n/a |
| Debt Repayment | n/a | n/a | n/a | -36.43M | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | -360K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -141K | -427K | 183K | 228K | 169K | 465K | 496K | 49.49M | n/a | 47.72M |
| Financial Cash Flow | -141K | 82.39M | 1.65M | 39.78M | 61.81M | 4.99M | 125.91M | 49.49M | n/a | 47.72M |
| Net Cash Flow | -10.75M | -301K | -11.88M | -15.56M | 13.83M | -18.73M | 39.3M | 6.18M | -39.78M | 43.53M |
| Free Cash Flow | -34.09M | -25.34M | -29.2M | -56.37M | -137.19M | -65.11M | -52.87M | -28.27M | -2.32M | -4.18M |